| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |